Search

Eppert, K., K. Takenaka, E. R. Lechman, L. Waldron, B. Nilsson, P. Galen, K. H. Metzeler, et al. 2011. “Stem Cell Gene Expression Programs Influence Clinical Outcome in Human Leukemia”. Nat Med 17: 1086-93.

Fang, C., B. D’Souza, C. F. Thompson, M. C. Clifton, J. W. Fairman, B. Fulroth, A. Leed, et al. 2014. “Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1)”. ACS Med Chem Lett 5: 1308-12.

Geller, L. T., M. Barzily-Rokni, T. Danino, O. H. Jonas, N. Shental, D. Nejman, N. Gavert, et al. 2017. “Potential Role of Intratumor Bacteria in Mediating Tumor Resistance to the Chemotherapeutic Drug Gemcitabine”. Science 357: 1156-60.

Golub, T. R. 2004. “Toward a Functional Taxonomy of Cancer”. Cancer Cell 6: 107-8.

Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. “Fusion of PDGF Receptor Beta to a Novel Ets-Like Gene, Tel, in Chronic Myelomonocytic Leukemia With T(5;12) Chromosomal Translocation”. Cell 77: 307-16.

Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1997. “The TEL Gene Contributes to the Pathogenesis of Myeloid and Lymphoid Leukemias by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 220: 67-79.

Hieronymus, H., J. Lamb, K. N. Ross, X. P. Peng, C. Clement, A. Rodina, M. Nieto, et al. 2006. “Gene Expression Signature-Based Chemical Genomic Prediction Identifies a Novel Class of HSP90 Pathway Modulators”. Cancer Cell 10: 321-30.

Ikeda, S., S. W. Kong, J. Lu, E. Bisping, H. Zhang, P. D. Allen, T. R. Golub, B. Pieske, and W. T. Pu. 2007. “Altered MicroRNA Expression in Human Heart Disease”. Physiol Genomics 31: 367-73.

Wasswa, George. 2014. “A Re-Examination of Race in the U.S.”. Political Science 1 (15).

Mathews, Juanita. 2022. “Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma.”